BIOS Capital Management, LP
Follow13F filer, CIK 1813845, Fort Worth, TX
BIOS Capital Management, LP reported $79,177,472 across 6 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-25-048606
- Period
- 2025-03-31
- Reported value
- $79.2M
- Holdings
- 6
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Part of the filer group BIOS Capital Management, LP
How groups are builtHoldings, Q1 2025
Share positions as resolved from 13F-HR 0001104659-25-048606, largest first. % of portfolio is the value over $79,177,472, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ACTUACTUATE THERAPEUTICS INC | 9,893,651 | $67M | 84.59% | 0 | Timeline | ||
| LTRNLANTERN PHARMA INC | 1,207,709 | $4.28M | 5.4% | 0 | Timeline | ||
| RNTXREIN THERAPEUTICS INC | 1,690,751 | $2.99M | 3.78% | 0 | Timeline | ||
| CGTXCOGNITION THERAPEUTICS INC | 6,000,000 | $2.52M | 3.19% | 0 | Timeline | ||
| IN8BIO INCIN8BIO INC | 8,600,001 | $1.43M | 1.8% | 0 | |||
| IRDOPUS GENETICS INC | 995,249 | $977K | 1.23% | 0 | Timeline |
How Q1 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001104659-25-048606 | base | 2025-05-14 | acceptance time not in the bulk data set |